A Prospective Study to Evaluate the ConforMIS iTotal® (PS) Knee Replacement System
Status: | Recruiting |
---|---|
Conditions: | Arthritis, Osteoarthritis (OA) |
Therapuetic Areas: | Rheumatology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 11/4/2018 |
Start Date: | May 1, 2017 |
End Date: | May 2028 |
Contact: | Marc Quartulli |
Email: | Marc.Quartulli@conformis.com |
Phone: | 781-345-9191 |
This is a prospective clinical study designed to observe the long-term clinical outcomes of
total knee arthroplasty using a patient-specific, posterior stabilized implant in patients
with osteoarthritis.
total knee arthroplasty using a patient-specific, posterior stabilized implant in patients
with osteoarthritis.
The study is prospective. Subjects will be implanted with an iTotal® PS Knee Replacement
System. The study will include a minimum of 100 subjects across up to 10 sites. The patients
enrolled in this study may represent the first cases of the iTotal PS KRS implanted at a
particular site; data collected for the first 15 patients at each site will be analyzed
separately from the rest of the enrolled population. This will provide visibility towards
determining if there exists a learning curve in the implantation process of the iTotal PS
KRS. The study sites will be located in the United States.
System. The study will include a minimum of 100 subjects across up to 10 sites. The patients
enrolled in this study may represent the first cases of the iTotal PS KRS implanted at a
particular site; data collected for the first 15 patients at each site will be analyzed
separately from the rest of the enrolled population. This will provide visibility towards
determining if there exists a learning curve in the implantation process of the iTotal PS
KRS. The study sites will be located in the United States.
Inclusion Criteria:
- Clinical condition included in the approved Indications For Use for the iTotal® PS
- Osteoarthritis, as confirmed by the investigator's assessment of disease status at
screening visit that warrants a TKR procedure. Disease status is assessed by Clinical
and Radiographic assessment.
- Willingness to participate in the clinical study, to give informed consent, and to
attend all follow-up visits
- > 18 years of age
Exclusion Criteria:
- Simultaneous bilateral procedure required
- BMI > 40
- Active malignancy (defined as a history of any invasive malignancy - except non-
melanoma skin cancer), unless patient has been treated with curative intent and there
have been no clinical signs or symptoms of the malignancy for at least 5 years
- Poorly controlled diabetes
- Neuromuscular conditions which prevent patient from participating in study activities
- Active local or systemic infection
- Immunocompromised
- Fibromyalgia or other general body pain related condition
- Rheumatoid arthritis or other forms of inflammatory joint disease
- Loss of bone or musculature, osteonecrosis, neuromuscular or vascular compromise in
the area of the joint to be operated on, to an extent that the procedure is
unjustified
- Diagnosed with or receiving treatment for Osteoporosis
- Other physical disability affecting the hips, spine, or contralateral knee
- Severe instability due to advanced loss of osteochondral structure
- Prior arthroplasty of the affected knee, including High Tibial Osteotomy (HTO)
- Unwilling or unable to comply with study requirements
- Participation in another clinical study which would confound results
- Allergy to any of the implant materials
We found this trial at
4
sites
Austin, Texas 78751
Principal Investigator: Eric M Heinrich, MD
Phone: 512-583-0217
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Morrisville, Vermont 05661
Principal Investigator: Bryan Huber, MD
Phone: 802-888-8405
Click here to add this to my saved trials